Atlas Trials

Cross-Sectional Iloperidone IVGTT

Clinical trial NCT01686815 · COMPLETED

Trial details

NCT number
NCT01686815
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
SchizophreniaSerious Mental IllnessMetabolic SyndromeInsulin ResistanceGlucose Metabolism
Start date
2012-10-01
Primary completion
2016-05-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.